TACSTD2 and squamous cell carcinoma of penis: Their results showed an increase in TROP-2 expression in individuals with PSCC compared to healthy controls (p < 0.0001), with a notable elevation in TROP-2 expression in serum samples obtained from patients with PSCC (p < 0.01).